Global Body Worn Insect Repellent Industry

Global Body Worn Insect Repellent Industry

  • September 2020 •
  • 183 pages •
  • Report ID: 5960582 •
  • Format: PDF
Global Body Worn Insect Repellent Market to Reach $626.4 Million by 2027

Amid the COVID-19 crisis, the global market for Body Worn Insect Repellent estimated at US$364.6 Million in the year 2020, is projected to reach a revised size of US$626.4 Million by 2027, growing at a CAGR of 8% over the analysis period 2020-2027. Apparels, one of the segments analyzed in the report, is projected to record a 9.2% CAGR and reach US$146.3 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Oils & Creams segment is readjusted to a revised 8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $98.5 Million, While China is Forecast to Grow at 12.2% CAGR

The Body Worn Insect Repellent market in the U.S. is estimated at US$98.5 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$143.1 Million by the year 2027 trailing a CAGR of 12.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.3% and 7.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Stickers & Patches Segment to Record 7.4% CAGR

In the global Stickers & Patches segment, USA, Canada, Japan, China and Europe will drive the 6.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$92.4 Million in the year 2020 will reach a projected size of US$146.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$86.6 Million by the year 2027, while Latin America will expand at a 8.7% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 183-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,
  • Acorn Pharmacueticals
  • All Terrain
  • Avon Products, Inc.
  • Babyganics products, pbc
  • Chase Products Co.
  • ExOfficio LLC
  • Insect Shield International, LLC
  • Lanxess AG
  • Omega Pharma AS
  • S. C. Johnson & Son, Inc.
  • Sawyer Products Inc.
  • Spectrum Brands Holdings, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Tender Corporation
  • The Coleman Company Inc.
  • The Orvis Company Inc.
  • Wisconsin Pharmacal Company, LLC